Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 1.00 |
| ▸ | MEN1 | O00255 | 2/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 2/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 2/20 | 1.00 |
| ▸ | MAPT | P10636 | 2/20 | 0.95 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.95 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.95 |
| ▸ | SQLE | Q14534 | 7/20 | 0.67 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.56 |
| ▸ | ICMT | O60725 | 1/20 | 0.53 |
| ▸ | ATM | Q13315 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Nerol SCHEMBL19825 | 1.00 | KMT2A (1.00) | KMT2AMEN1CYP3A4ALOX15MAPT | |
| Geraniol SCHEMBL2874022 | 1.00 | KMT2A (1.00) | KMT2AMEN1CYP3A4ALOX15MAPT | |
| Geraniol SCHEMBL30529087 | 1.00 | KMT2A (1.00) | KMT2AMEN1CYP3A4ALOX15MAPT | |
| Geraniol SCHEMBL8676054 | 1.00 | KMT2A (1.00) | KMT2AMEN1CYP3A4ALOX15MAPT | |
| Geraniol SCHEMBL19824 | 1.00 | KMT2A (1.00) | KMT2AMEN1CYP3A4ALOX15MAPT | |
| Geraniol SCHEMBL11280775 | 1.00 | KMT2A (1.00) | KMT2AMEN1CYP3A4ALOX15MAPT | |
| Geraniol SCHEMBL9051249 | 1.00 | KMT2A (1.00) | KMT2AMEN1CYP3A4ALOX15MAPT | |
| Geraniol SCHEMBL118988 | 1.00 | KMT2A (1.00) | KMT2AMEN1CYP3A4ALOX15MAPT | |
| Geraniol SCHEMBL21173796 | 1.00 | KMT2A (1.00) | KMT2AMEN1CYP3A4ALOX15MAPT | |
| Geraniol SCHEMBL19826 | 1.00 | KMT2A (1.00) | KMT2AMEN1CYP3A4ALOX15MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11612575-B2 | Combination therapies with disulfiram | Spring Discovery, Inc. (US) | 2023-03-28 | — | — | US | disclosed |
| US-20220087956-A1 | COMBINATION THERAPIES WITH DISULFIRAM | WINTER ACQUISITION SUB, INC. | 2022-03-24 | — | — | US | disclosed |
| US-11065214-B1 | Combination therapies with disulfiram | Spring Discovery, Inc. (US) | 2021-07-20 | — | — | US | disclosed |
| US-11062794-B2 | Olfactory signature and odorant mixture having the same | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2021-07-13 | — | — | US | disclosed |
| US-11033516-B1 | Combination therapies with disulfiram | Spring Discovery, Inc. (US) | 2021-06-15 | — | — | US | disclosed |
| US-20180253534-A1 | OLFACTORY SIGNATURE AND ODORANT MIXTURE HAVING THE SAME | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2018-09-06 | — | — | US | disclosed |
| EP-3365418-A2 | PARTICLES FOR MALODOR REDUCTION | The Procter and Gamble Company (US) | 2018-08-29 | — | — | EP | disclosed |
| EP-3197510-A1 | DELIVERY SYSTEMS COMPRISING MALODOR REDUCTION COMPOSITIONS | The Procter & Gamble Company (US) | 2017-08-02 | — | — | EP | disclosed |
| EP-3197422-A1 | CLEANING AND/OR TREATMENT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | The Procter & Gamble Company (US) | 2017-08-02 | — | — | EP | disclosed |
| EP-3197426-A1 | FRESHENING COMPOSITIONS AND DEVICES COMPRISING SAME | THE PROCTER & GAMBLE COMPANY (US) | 2017-08-02 | — | — | EP | disclosed |
| WO-2016049389-A1 | MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | disclosed |
| WO-2016049455-A1 | PERSONAL CARE COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | disclosed |
| US-8580728-B2 | Use of fragrance compositions for the prevention of the development of indole base malodours from fecal and urine based soils | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2013-11-12 | — | — | US | disclosed |
| EP-1884251-B1 | Use of fragrance compositions for restricting the formation of indole from faecal and urine based soils | TAKASAGO PERFUMERY CO LTD (JP) | 2013-08-28 | — | — | EP | disclosed |
| WO-2013035070-A1 | OLFACTORY SIGNATURE AND ODORANT MIXTURE HAVING THE SAME | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2013-03-14 | — | — | WO | disclosed |
| US-20100104525-A1 | USE OF FRAGRANCE COMPOSITIONS FOR THE PREVENTION OF THE DEVELOPMENT OF INDOLE BASE MALODOURS FROM FECAL AND URINE BASED SOILS | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2010-04-29 | — | — | US | disclosed |
| US-20080032912-A1 | Use of fragrance compositions for the prevention of the development of indole base malodours from fecal and urine based soils | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2008-02-07 | — | — | US | disclosed |
| EP-1884251-A1 | Use of fragrance compositions for the prevention of the development of indole based malodours from faecal and urine based soils | Takasago International Corporation (JP) | 2008-02-06 | — | — | EP | disclosed |
| US-5716928-A | ADMINISTERING DRUG CONCURRENTLY WITH ESSENTIAL OIL | AVMAX, INC. (US) | 1998-02-10 | — | — | US | disclosed |
| US-5665386-A | Use of essential oils to increase bioavailability of oral pharmaceutical compounds | AVMAX, INC. (US) | 1997-09-09 | — | — | US | disclosed |